AG
FCSC

Advisor Group’s Fibrocell Science Inc. FCSC Stock Holding History

Advisor Group’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-54
Closed – – 5489
2019
Q1 		$0 Hold
54
– – ﹤0.01% 5423
2018
Q4 		$0 Hold
54
– – ﹤0.01% 5351
2018
Q3 		$0 Hold
54
– – ﹤0.01% 5321
2018
Q2 		$0 Buy
54
+1
+2% +$3 ﹤0.01% 5135
2018
Q1 		$0 Hold
53
– – ﹤0.01% 5154
2017
Q4 		$0 Hold
53
– – ﹤0.01% 5150
2017
Q3 		$1K Hold
53
– – ﹤0.01% 4775
2017
Q2 		$1K Buy
+53
New +$654 ﹤0.01% 4731

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Advisor Group's FCSC Position: Q2 2019 in Review

Advisor Group sold out of Fibrocell Science Inc. (FCSC) in Q2 2019, closing a stake of 54 shares.

Advisor Group first reported a position in FCSC in Q2 2017 and held it in 8 quarters. The position peaked at $1K in Q3 2017. 20 funds tracked by Wall St. Rank hold FCSC as of Q2 2019.

  • Advisor Group reported no remaining Fibrocell Science Inc. position as of Q2 2019 after selling out during the quarter.
  • Advisor Group sold 54 Fibrocell Science Inc. shares in Q2 2019.
  • Advisor Group first reported a position in Fibrocell Science Inc. in Q2 2017 and held it in 8 quarters.
  • Advisor Group's Fibrocell Science Inc. position peaked at $1K in Q3 2017.
  • 20 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2019.

Based on Advisor Group's 13F filing for Q2 2019, filed 31 Jul 2019.